Scientists uncover links between lysosomal storage diseases and cancer https://doi.org/10.1038/s41436-019-0588-9
Lysosomal storage diseases (LSDs) are a group of more than 50 mostly autosomal recessive monogenic lysosomal catabolism disorders that affect 1 in 5000 live births. Defects in lysosomal proteins lead to the accumulation of macromolecules and ultimately cellular stress, dysfunction, and death in many cases without treatment. As a result, patients with LSDs suffer impaired organ function and many have short life expectancy. Additionally, clinical observations have revealed that patients with two LSDs are at increased risk of cancer, and disruption of lysosomal homeostasis is linked to several cellular processes that can induce malignancies. Yet scientists remain uncertain about the relationship between lysosomal dysfunction and cancer. Now, in an extensive association analysis between cancer and germline variants in 42 causal LSD genes, Shin and colleagues show that carriers of potentially pathogenic variants (PPVs) in LSD genes not only are at increased risk of cancer but also develop the malady earlier than noncarriers. The researchers compared sequencing and clinical data from more than 2500 cancer patients from the Pan-Cancer Analysis of Whole Genomes (PACWG) to publicly available variant call sets of about 2500 genomes in the 1000 Genomes Project and more than 53,000 exomes from a subset of the Exome Aggregation Consortium. The analysis revealed that the proportion of individuals carrying PPVs was significantly higher in the Pan-Cancer cohort (20.7%) than in the 1000 Genomes cohort (13.5%). Additional association analyses revealed that 19 cancer types harbor PPVs in at least 1 LSD gene and that PPVs in 18 genes were associated with at least one cancer type. When the researchers assessed age at cancer diagnosis in PPV carriers versus noncarriers, they found that cancer developed earlier in carriers. For example, PPV carriers developed chronic myeloid disorder at a median age of 45.5 years, whereas median age of diagnosis for noncarriers was 58.5 years. The researchers conclude that carriers of PPVs in LSD genes are at increased risk of cancer. 
